{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T09:47:13Z","timestamp":1785923233070,"version":"3.56.0"},"reference-count":203,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaci.2026.06.004","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:18:39Z","timestamp":1781885919000},"page":"342-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tissue remodeling in eosinophilic esophagitis"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2622-7081","authenticated-orcid":false,"given":"Seema S.","family":"Aceves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario C.","family":"Manresa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan S.","family":"Dellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret H.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo J.","family":"Lucendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc E.","family":"Rothenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.06.004_bib1","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE Conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jaci.2013.02.030","article-title":"High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders","volume":"132","author":"Abonia","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib3","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.jaip.2024.07.011","article-title":"Losartan treatment reduces esophageal eosinophilic inflammation in a subset of eosinophilic esophagitis","volume":"12","author":"Abonia","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.06.004_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/j.gastro.2017.06.067","article-title":"Epidemiology and natural history of eosinophilic esophagitis","volume":"154","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cgh.2024.09.031","article-title":"Prevalence and costs of eosinophilic esophagitis in the United States","volume":"23","author":"Thel","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doy015","article-title":"Natural history of eosinophilic esophagitis: a systematic review of epidemiology and disease course","volume":"31","author":"Shaheen","year":"2018","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaci.2026.06.004_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.14309\/ajg.0000000000003194","article-title":"ACG clinical guideline: diagnosis and management of eosinophilic esophagitis","volume":"120","author":"Dellon","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib8","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1016\/j.cgh.2023.06.005","article-title":"Global incidence and prevalence of eosinophilic esophagitis, 1976-2022: a systematic review and meta-analysis","volume":"21","author":"Hahn","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib9","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.cgh.2023.12.017","article-title":"Eosinophilic esophagitis: seeing only the tip of the iceberg","volume":"22","author":"Ray","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.iac.2008.10.003","article-title":"Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis","volume":"29","author":"Aceves","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2026.06.004_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.iac.2023.12.008","article-title":"Histopathology of eosinophilic esophagitis","volume":"44","author":"Collins","year":"2024","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2026.06.004_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.gtc.2014.02.007","article-title":"Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases","volume":"43","author":"Collins","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaci.2026.06.004_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fmed.2017.00128","article-title":"Tissue remodeling in chronic eosinophilic esophageal inflammation: parallels in asthma and therapeutic perspectives","volume":"4","author":"Nhu","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2026.06.004_bib14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.gie.2013.10.027","article-title":"A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease","volume":"79","author":"Dellon","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jaci.2026.06.004_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.gtc.2014.02.015","article-title":"Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis","volume":"43","author":"Hirano","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaci.2026.06.004_bib16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1055\/s-0042-107340","article-title":"Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis","volume":"48","author":"Chen","year":"2016","journal-title":"Endoscopy"},{"key":"10.1016\/j.jaci.2026.06.004_bib17","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cgh.2022.08.044","article-title":"Esophageal distensibility defines fibrostenotic severity in pediatric eosinophilic esophagitis","volume":"21","author":"Hoffmann","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib18","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/ajg.2017.131","article-title":"Influence of age and eosinophilic esophagitis on esophageal distensibility in a pediatric cohort","volume":"112","author":"Menard-Katcher","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaci.2006.10.016","article-title":"Esophageal remodeling in pediatric eosinophilic esophagitis","volume":"119","author":"Aceves","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.gastro.2010.09.037","article-title":"Mechanical properties of the esophagus in eosinophilic esophagitis","volume":"140","author":"Kwiatek","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.gastro.2025.07.042","article-title":"Histologic response is associated with improved esophageal distensibility and symptom burden in pediatric eosinophilic esophagitis","volume":"170","author":"Kennedy","year":"2026","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib22","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.14309\/ajg.0000000000001950","article-title":"Diagnostic delay in patients with eosinophilic esophagitis has not changed since the first description 30 years ago: diagnostic delay in eosinophilic esophagitis","volume":"117","author":"Murray","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib23","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.dld.2021.05.017","article-title":"Diagnostic delay and misdiagnosis in eosinophilic oesophagitis","volume":"53","author":"Lenti","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaci.2026.06.004_bib24","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1007\/s12325-020-01463-2","article-title":"Documenting the journey of patients with eosinophilic esophagitis and the impact of the disease on patients and their caregivers: a cross-sectional, qualitative research study","volume":"37","author":"Pokrzywinski","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaci.2026.06.004_bib25","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2013.08.015","article-title":"Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner","volume":"145","author":"Schoepfer","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ueg2.12216","article-title":"Close follow-up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long-term management of eosinophilic esophagitis","volume":"10","author":"Bon","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.jaci.2026.06.004_bib27","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cgh.2021.10.028","article-title":"A gap in care leads to progression of fibrosis in eosinophilic esophagitis patients","volume":"20","author":"Chang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s10620-022-07610-9","article-title":"Worsened fibrostenotic outcomes in eosinophilic esophagitis patients due to COVID-19-related endoscopy cancellations","volume":"68","author":"Ocampo","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaci.2026.06.004_bib29","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jaci.2019.06.015","article-title":"Evaluation of long-term course in children with eosinophilic esophagitis reveals distinct histologic patterns and clinical characteristics","volume":"144","author":"Collins","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib30","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.cgh.2020.08.027","article-title":"Effectiveness and safety of high- vs low-dose swallowed topical steroids for maintenance treatment of eosinophilic esophagitis: a multicenter observational study","volume":"19","author":"Greuter","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doaa120","article-title":"Treatment with compounded fluticasone suspension improves the clinical, endoscopic, and histologic features of eosinophilic esophagitis","volume":"34","author":"Ketchem","year":"2021","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaci.2026.06.004_bib32","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/all.12455","article-title":"Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis","volume":"69","author":"Kuchen","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.06.004_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00535-017-1397-z","article-title":"The role of maintenance therapy in eosinophilic esophagitis: who, why, and how?","volume":"53","author":"Philpott","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cgh.2018.05.045","article-title":"Maintenance treatment of eosinophilic esophagitis with swallowed topical steroids alters disease course over a 5-year follow-up period in adult patients","volume":"17","author":"Greuter","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2147\/CEG.S175061","article-title":"Eosinophilic esophagitis: early diagnosis is the key","volume":"12","author":"Muir","year":"2019","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaci.2018.10.067","article-title":"Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-alpha","volume":"144","author":"Kasagi","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib37","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jaci.2015.09.020","article-title":"Rigid substrate induces esophageal smooth muscle hypertrophy and eosinophilic esophagitis fibrotic gene expression","volume":"137","author":"Tkachenko","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MPG.0000000000001100","article-title":"Eosinophilic esophagitis-associated chemical and mechanical microenvironment shapes esophageal fibroblast behavior","volume":"63","author":"Muir","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2026.06.004_bib39","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaci.2024.01.007","article-title":"Eosinophilic esophagitis: shifting immune complexity beyond the eosinophil","volume":"153","author":"Lewis","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib40","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jaci.2023.10.002","article-title":"A synthesis and subgroup analysis of the eosinophilic esophagitis tissue transcriptome","volume":"153","author":"Jacobse","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172143","article-title":"The minichromosome maintenance complex drives esophageal basal zone hyperplasia","volume":"8","author":"Rochman","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2026.06.004_bib42","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/all.15557","article-title":"Fibrostenotic eosinophilic esophagitis phenotype is defined by a proliferative gene signature","volume":"78","author":"Menard-Katcher","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.06.004_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.603295","article-title":"Eosinophils in eosinophilic esophagitis: the road to fibrostenosis is paved with good intentions","volume":"11","author":"Doyle","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib44","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2468-1253(18)30096-7","article-title":"Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study","volume":"3","author":"Shoda","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib45","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jaci.2020.01.051","article-title":"Esophageal type 2 cytokine expression heterogeneity in eosinophilic esophagitis in a multisite cohort","volume":"145","author":"Dunn","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib46","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis","volume":"141","author":"Assa\u2019ad","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib47","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1136\/gutjnl-2023-330337","article-title":"Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial","volume":"72","author":"Dellon","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2026.06.004_bib48","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S2468-1253(23)00145-0","article-title":"Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"8","author":"Kliewer","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib49","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2313318","article-title":"Eosinophil depletion with benralizumab for eosinophilic esophagitis","volume":"390","author":"Rothenberg","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.06.004_bib50","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib51","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaci.2006.09.007","article-title":"Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis","volume":"118","author":"Stein","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2026.06.004_bib53","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jaci.2022.02.025","article-title":"Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission","volume":"149","author":"Ben-Baruch Morgenstern","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib54","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1038\/s41467-024-47647-0","article-title":"An esophagus cell atlas reveals dynamic rewiring during active eosinophilic esophagitis and remission","volume":"15","author":"Ding","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.06.004_bib55","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jaci.2025.01.008","article-title":"A molecular basis for milk allergen immune recognition in eosinophilic esophagitis","volume":"155","author":"Dilollo","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib56","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1111\/all.14854","article-title":"Peripheral markers of allergen-specific immune activation predict clinical allergy in eosinophilic esophagitis","volume":"76","author":"Dilollo","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.06.004_bib57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21037\/tgh-22-15","article-title":"EoE behaves as a unique Th2 disease: a narrative review","volume":"8","author":"Rabinowitz","year":"2023","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adg6360","article-title":"TSLP shapes the pathogenic responses of memory CD4(+) T cells in eosinophilic esophagitis","volume":"16","author":"Rochman","year":"2023","journal-title":"Sci Signal"},{"key":"10.1016\/j.jaci.2026.06.004_bib59","article-title":"Type 2 inflammation in eosinophilic esophagitis: from pathophysiology to therapeutic targets","volume":"12","author":"Racca","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jaci.2026.06.004_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.05.001","article-title":"Allergic components of eosinophilic esophagitis","volume":"142","author":"Spergel","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib61","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S2468-1253(23)00012-2","article-title":"One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial","volume":"8","author":"Kliewer","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib62","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2024.08.023","article-title":"One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: a multisite randomized trial","volume":"155","author":"Kliewer","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib63","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.gastro.2019.02.042","article-title":"Penetration of the esophageal epithelium by dust mite antigen in patients with eosinophilic esophagitis","volume":"157","author":"Ravi","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib64","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41575-025-01086-4","article-title":"The oesophagus as an immune organ","volume":"22","author":"Rochman","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib65","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.gastha.2022.05.004","article-title":"Examining the role of type 2 inflammation in eosinophilic esophagitis","volume":"1","author":"Chehade","year":"2022","journal-title":"Gastro Hep Adv"},{"key":"10.1016\/j.jaci.2026.06.004_bib66","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaci.2010.08.050","article-title":"Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction","volume":"126","author":"Aceves","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib67","doi-asserted-by":"crossref","first-page":"224","DOI":"10.14309\/ajg.0000000000000474","article-title":"Mast cell infiltration is associated with persistent symptoms and endoscopic abnormalities despite resolution of eosinophilia in pediatric eosinophilic esophagitis","volume":"115","author":"Bolton","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib68","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/10935266211041086","article-title":"Acquired esophageal strictures in children: morphometric and immunohistochemical analyses","volume":"25","author":"Collins","year":"2022","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.jaci.2026.06.004_bib69","doi-asserted-by":"crossref","first-page":"G1087","DOI":"10.1152\/ajpgi.00070.2013","article-title":"Pathogenic role of mast cells in experimental eosinophilic esophagitis","volume":"304","author":"Niranjan","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jaci.2026.06.004_bib70","doi-asserted-by":"crossref","unstructured":"Dsilva A, Wagner A, Itan M, Rhone N, Avlas S, Gordon Y, et al. Distinct roles for thymic stromal lymphopoietin (TSLP) and IL-33 in experimental eosinophilic esophagitis [preprint March 1, 2025]. bioRxiv. https:\/\/doi.org\/10.1101\/2025.02.25.640192.","DOI":"10.1101\/2025.02.25.640192"},{"key":"10.1016\/j.jaci.2026.06.004_bib71","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cgh.2023.04.027","article-title":"The severity of reduced esophageal distensibility parallels eosinophilic esophagitis disease duration","volume":"22","author":"Araujo","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/JLB.5MR1017-395R","article-title":"Understanding fibrosis in eosinophilic esophagitis: are we there yet?","volume":"104","author":"Armbruster-Lee","year":"2018","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2026.06.004_bib73","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ajg.2016.238","article-title":"Swallowed fluticasone propionate is an effective long-term maintenance therapy for children with eosinophilic esophagitis","volume":"111","author":"Andreae","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib74","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0b013e31806ab384","article-title":"Esophageal subepithelial fibrosis in children with eosinophilic esophagitis","volume":"45","author":"Chehade","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2026.06.004_bib75","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MPG.0000000000002997","article-title":"Esophageal fibrosis in eosinophilic gastrointestinal diseases","volume":"72","author":"Thaker","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2026.06.004_bib76","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.gie.2017.12.020","article-title":"Obtaining adequate lamina propria for subepithelial fibrosis evaluation in pediatric eosinophilic esophagitis","volume":"87","author":"Wang","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jaci.2026.06.004_bib77","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ajg.2017.493","article-title":"Eosinophilic esophagitis: relationship of subepithelial eosinophilic inflammation with epithelial histology, endoscopy, blood eosinophils, and symptoms","volume":"113","author":"Schoepfer","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib78","first-page":"1620","article-title":"A practical update on pediatric eosinophilic esophagitis","volume":"10","author":"Votto","year":"2023","journal-title":"Children (Basel)"},{"key":"10.1016\/j.jaci.2026.06.004_bib79","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41395-018-0052-5","article-title":"The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort","volume":"113","author":"Warners","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib80","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MOG.0000000000000442","article-title":"Esophageal dilation in eosinophilic esophagitis: risks, benefits, and when to do it","volume":"34","author":"Lucendo","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib81","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","article-title":"Targeting fibrosis, mechanisms and cilinical trials","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2026.06.004_bib82","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1152\/physrev.00005.2021","article-title":"Development of antifibrotic therapy for stricturing Crohn\u2019s disease: lessons from randomized trials in other fibrotic diseases","volume":"102","author":"Lin","year":"2022","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jaci.2026.06.004_bib83","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1055\/s-0042-117274","article-title":"Comparison of different biopsy forceps models for tissue sampling in eosinophilic esophagitis","volume":"48","author":"Bussmann","year":"2016","journal-title":"Endoscopy"},{"key":"10.1016\/j.jaci.2026.06.004_bib84","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00535-019-01624-3","article-title":"Clinical relevance of esophageal subepithelial activity in eosinophilic esophagitis","volume":"55","author":"Hirano","year":"2020","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib85","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.gie.2025.01.018","article-title":"Yield of esophageal biopsy patterns for the diagnosis of eosinophilic esophagitis","volume":"102","author":"Muftah","year":"2025","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jaci.2026.06.004_bib86","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gutjnl-2011-301817","article-title":"Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system","volume":"62","author":"Hirano","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2026.06.004_bib87","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MOG.0000000000000272","article-title":"Functional lumen imaging probe: the FLIP side of esophageal disease","volume":"32","author":"Carlson","year":"2016","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib88","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cgh.2016.10.022","article-title":"Functional lumen imaging probe for the management of esophageal disorders: expert review from the Clinical Practice Updates Committee of the AGA Institute","volume":"15","author":"Hirano","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib89","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.gtc.2020.04.002","article-title":"EndoFLIP in the esophagus: assessing sphincter function, wall stiffness, and motility to guide treatment","volume":"49","author":"Donnan","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaci.2026.06.004_bib90","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.14309\/ajg.0000000000002661","article-title":"Esophageal remodeling correlates with eating behaviors in pediatric eosinophilic esophagitis","volume":"119","author":"Kennedy","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib91","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cgh.2013.03.020","article-title":"Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis","volume":"11","author":"Nicodeme","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib92","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anai.2022.10.026","article-title":"Breaking down the complex pathophysiology of eosinophilic esophagitis","volume":"130","author":"Underwood","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib93","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/mi.2008.15","article-title":"Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses","volume":"1","author":"Blanchard","year":"2008","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib94","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2007.10.024","article-title":"IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids","volume":"120","author":"Blanchard","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib95","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1172\/JCI26679","article-title":"Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis","volume":"116","author":"Blanchard","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.06.004_bib96","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaci.2015.05.048","article-title":"Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitis","volume":"136","author":"Doherty","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib97","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jaci.2014.04.004","article-title":"TGF-beta1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis","volume":"134","author":"Beppu","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib98","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2016.02.028","article-title":"TGF-beta1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis","volume":"138","author":"Rawson","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib99","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaci.2021.01.023","article-title":"A unique esophageal extracellular matrix proteome alters normal fibroblast function in severe eosinophilic esophagitis","volume":"148","author":"Hsieh","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2018.10.051","article-title":"RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis","volume":"156","author":"Hirano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib101","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaci.2020.03.045","article-title":"An anti-IL-13 antibody reverses epithelial-mesenchymal transition biomarkers in eosinophilic esophagitis: phase 2 trial results","volume":"146","author":"Gann","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib102","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yexcr.2014.08.026","article-title":"Esophageal epithelial cells acquire functional characteristics of activated myofibroblasts after undergoing an epithelial to mesenchymal transition","volume":"330","author":"Muir","year":"2015","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jaci.2026.06.004_bib103","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.gastro.2014.05.036","article-title":"Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE","volume":"147","author":"Clayton","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib104","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1111\/all.15826","article-title":"Immunoglobulin G4 in eosinophilic esophagitis: immune complex formation and correlation with disease activity","volume":"78","author":"Medernach","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.06.004_bib105","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.012661","article-title":"Unraveling the pathophysiological mechanisms of phospholamban R14del cardiomyopathy: a comprehensive overview","volume":"18","author":"Maas","year":"2025","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jaci.2026.06.004_bib106","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1006\/jmcc.2000.1270","article-title":"Phospholamban and cardiac contractile function","volume":"32","author":"Brittsan","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jaci.2026.06.004_bib107","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00395-014-0435-8","article-title":"The alteration of Hippo\/YAP signaling in the development of hypertrophic cardiomyopathy","volume":"109","author":"Wang","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jaci.2026.06.004_bib149","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.mucimm.2024.02.007","article-title":"Mechanotransduction-induced interplay between phospholamban and yes-activated protein induces smooth muscle cell hypertrophy","volume":"17","author":"Rawson","year":"2024","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib108","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/exd.14193","article-title":"Cellular and molecular mechanisms in fibrosis","volume":"30","author":"Dees","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib109","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jaci.2012.03.005","article-title":"Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment","volume":"129","author":"Kagalwalla","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00535-018-1498-3","article-title":"Epithelial-stromal crosstalk and fibrosis in eosinophilic esophagitis","volume":"54","author":"Muir","year":"2019","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib111","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jcmgh.2024.01.020","article-title":"Epithelial-fibroblast crosstalk in eosinophilic esophagitis","volume":"17","author":"Muir","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib112","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/j.gastro.2020.07.035","article-title":"Increased production of LIGHT by T cells in eosinophilic esophagitis promotes differentiation of esophageal fibroblasts toward an inflammatory phenotype","volume":"159","author":"Manresa","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib113","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.4049\/jimmunol.2200326","article-title":"A deficiency in the cytokine TNFSF14\/LIGHT limits inflammation and remodeling in murine eosinophilic esophagitis","volume":"209","author":"Manresa","year":"2022","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib122","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41385-022-00486-y","article-title":"The LIGHT switch: mechanisms of fibroblast pathology in eosinophilic esophagitis","volume":"15","author":"Chua","year":"2022","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib114","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41385-021-00472-w","article-title":"LIGHT controls distinct homeostatic and inflammatory gene expression profiles in esophageal fibroblasts via differential HVEM and LTbetaR-mediated mechanisms","volume":"15","author":"Manresa","year":"2022","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib205","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jaci.2022.03.022","article-title":"Esophageal remodeling in eosinophilic esophagitis: Relationships to luminal captured biomarkers of inflammation and periostin","volume":"150","author":"Muir","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib115","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.yexcr.2012.12.002","article-title":"Esophageal epithelial and mesenchymal cross-talk leads to features of epithelial to mesenchymal transition in vitro","volume":"319","author":"Muir","year":"2013","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jaci.2026.06.004_bib116","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MPG.0000000000002144","article-title":"Interleukin 9 alters epithelial barrier and E-cadherin in eosinophilic esophagitis","volume":"68","author":"Doshi","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2026.06.004_bib117","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41385-019-0214-9","article-title":"TGFbeta1 single-nucleotide polymorphism C-509T alters mucosal cell function in pediatric eosinophilic esophagitis","volume":"13","author":"Duong","year":"2020","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib118","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2024.11.028","article-title":"Eosinophilic esophagitis drives tissue fibroblast regenerative programs toward pathologic dysfunction","volume":"155","author":"Jumabay","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib119","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jcmgh.2022.01.018","article-title":"CD73(+) epithelial progenitor cells that contribute to homeostasis and renewal are depleted in eosinophilic esophagitis","volume":"13","author":"Hara","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaci.2025.09.006","article-title":"Resolution of epithelial dysfunction in eosinophilic esophagitis is mediated by an HIF-1alpha-CD73-adenosine signaling axis","volume":"157","author":"Kellett","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib121","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-beta signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"key":"10.1016\/j.jaci.2026.06.004_bib123","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MPG.0000000000000343","article-title":"Smad3-deficient mice have reduced esophageal fibrosis and angiogenesis in a model of egg-induced eosinophilic esophagitis","volume":"59","author":"Cho","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2026.06.004_bib124","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1053\/j.gastro.2014.01.051","article-title":"T-helper 2 cytokines, transforming growth factor beta1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis","volume":"146","author":"Rieder","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib125","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abp9940","article-title":"Epithelial-intrinsic defects in TGFbetaR signaling drive local allergic inflammation manifesting as eosinophilic esophagitis","volume":"8","author":"Laky","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib126","doi-asserted-by":"crossref","first-page":"195ra94","DOI":"10.1126\/scitranslmed.3006448","article-title":"TGFbeta receptor mutations impose a strong predisposition for human allergic disease","volume":"5","author":"Frischmeyer-Guerrerio","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2026.06.004_bib127","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cgh.2020.09.040","article-title":"Plasminogen activator inhibitor-1 as a marker of esophageal functional changes in pediatric eosinophilic esophagitis","volume":"20","author":"Williamson","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib128","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1172\/JCI125917","article-title":"Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis","volume":"129","author":"Wen","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.06.004_bib129","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi5586","article-title":"Clonally expanded, GPR15-expressing pathogenic effector TH2 cells are associated with eosinophilic esophagitis","volume":"6","author":"Morgan","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib130","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.1000471","article-title":"IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway","volume":"185","author":"Zuo","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib133","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1053\/j.gastro.2021.10.016","article-title":"Loss of endothelial TSPAN12 promotes fibrostenotic eosinophilic esophagitis via endothelial cell-fibroblast crosstalk","volume":"162","author":"Shoda","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib134","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2021.11.011","article-title":"Not hard to swallow\u2014understanding endothelial-fibroblast crosstalk in eosinophilic esophagitis","volume":"162","author":"Beveridge","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib135","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1067\/mai.2003.1333","article-title":"IL-13 receptors and signaling pathways: an evolving web","volume":"111","author":"Hershey","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib136","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-5793(96)01462-7","article-title":"Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4\/IL-13 receptor complex","volume":"401","author":"Miloux","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaci.2026.06.004_bib137","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/all.15510","article-title":"Epithelial cell-expressed type II IL-4 receptor mediates eosinophilic esophagitis","volume":"78","author":"Avlas","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.06.004_bib138","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cgh.2020.03.036","article-title":"Long-term efficacy and tolerability of RPC4046 in an open-label extension trial of patients with eosinophilic esophagitis","volume":"19","author":"Dellon","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib139","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2019.09.052","article-title":"Approaches and challenges to management of pediatric and adult patients with eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib140","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.cgh.2019.01.030","article-title":"A conceptual approach to understanding treatment response in eosinophilic esophagitis","volume":"17","author":"Dellon","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox042","article-title":"Control of inflammation decreases the need for subsequent esophageal dilation in patients with eosinophilic esophagitis","volume":"30","author":"Runge","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaci.2026.06.004_bib142","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ajg.2009.657","article-title":"Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation","volume":"105","author":"Schoepfer","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib143","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib144","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.227900","article-title":"The myofibroblast at a glance","volume":"133","author":"Pakshir","year":"2020","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jaci.2026.06.004_bib145","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3390\/jcm9051423","article-title":"Mechanotransduction in wound healing and fibrosis","volume":"9","author":"Kuehlmann","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaci.2026.06.004_bib146","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10137","article-title":"Role of YAP\/TAZ in mechanotransduction","volume":"474","author":"Dupont","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.06.004_bib147","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1681\/ASN.2015121354","article-title":"Yap\/Taz deletion in Gli(+) cell-derived myofibroblasts attenuates fibrosis","volume":"28","author":"Liang","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaci.2026.06.004_bib148","doi-asserted-by":"crossref","first-page":"L344","DOI":"10.1152\/ajplung.00300.2014","article-title":"Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis","volume":"308","author":"Liu","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jaci.2026.06.004_bib150","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aar2566","article-title":"Thrombospondin-1 promotes matrix homeostasis by interacting with collagen and lysyl oxidase precursors and collagen cross-linking sites","volume":"11","author":"Rosini","year":"2018","journal-title":"Sci Signal"},{"key":"10.1016\/j.jaci.2026.06.004_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.983412","article-title":"A role for age-associated alterations in esophageal epithelium in eosinophilic esophagitis-associated fibrosis","volume":"3","author":"Klochkova","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaci.2026.06.004_bib152","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/cea.13748","article-title":"Epigenetic methylation in eosinophilic esophagitis: molecular ageing and novel biomarkers for treatment response","volume":"50","author":"Jensen","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2026.06.004_bib153","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.dld.2021.05.025","article-title":"Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis","volume":"53","author":"Navarro","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaci.2026.06.004_bib154","doi-asserted-by":"crossref","first-page":"15","DOI":"10.15403\/jgld-4746","article-title":"Effect of proton pump inhibitor treatment in \u201cPPI non-responsive\u201d patients with eosinophilic esophagitis","volume":"32","author":"Thakkar","year":"2023","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.jaci.2026.06.004_bib155","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.dld.2022.03.006","article-title":"Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis","volume":"54","author":"Thakkar","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaci.2026.06.004_bib156","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1398-9995.2012.02881.x","article-title":"Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort","volume":"67","author":"Lieberman","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.06.004_bib157","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1398-9995.2009.02142.x","article-title":"Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids","volume":"65","author":"Aceves","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.06.004_bib158","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.gastro.2006.08.033","article-title":"A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis","volume":"131","author":"Konikoff","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib159","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2010.05.001","article-title":"Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial","volume":"139","author":"Dohil","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10620-010-1259-5","article-title":"Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis","volume":"56","author":"Abu-Sultaneh","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaci.2026.06.004_bib161","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jaci.2011.08.007","article-title":"Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study","volume":"128","author":"Lucendo","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib162","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/gutjnl-2014-308815","article-title":"A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis","volume":"65","author":"Miehlke","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2026.06.004_bib163","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaci.2015.05.045","article-title":"Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids","volume":"137","author":"Rajan","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib164","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/j.gastro.2016.11.021","article-title":"Budesonide oral suspension improves symptomatic, endoscopic, and histologic parameters compared with placebo in patients with eosinophilic esophagitis","volume":"152","author":"Dellon","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.gastro.2019.03.014","article-title":"Efficacy of budesonide vs fluticasone for initial treatment of eosinophilic esophagitis in a randomized controlled trial","volume":"157","author":"Dellon","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib166","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.gastro.2019.03.025","article-title":"Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial","volume":"157","author":"Lucendo","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib167","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/apt.15670","article-title":"Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis","volume":"51","author":"Hirano","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaci.2026.06.004_bib168","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1053\/j.gastro.2020.07.039","article-title":"Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis","volume":"159","author":"Straumann","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib169","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1016\/j.jaip.2021.06.058","article-title":"Ciclesonide impacts clinicopathological features of eosinophilic esophagitis","volume":"9","author":"Nistel","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.06.004_bib170","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.cgh.2022.02.013","article-title":"Fluticasone propionate orally disintegrating tablet (APT-1011) for eosinophilic esophagitis: randomized controlled trial","volume":"20","author":"Dellon","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib171","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cgh.2021.04.022","article-title":"Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial","volume":"20","author":"Hirano","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib172","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1081-1206(10)60359-6","article-title":"A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation","volume":"103","author":"Aceves","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib173","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jaci.2020.09.039","article-title":"Broad transcriptional response of the human esophageal epithelium to proton pump inhibitors","volume":"147","author":"Rochman","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib174","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/gutjnl-2012-302250","article-title":"Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD","volume":"62","author":"Cheng","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2026.06.004_bib175","article-title":"Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2026.06.004_bib176","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10620-020-06192-8","article-title":"Effect of maintenance therapy for eosinophilic esophagitis on need for recurrent dilation","volume":"66","author":"Schupack","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaci.2026.06.004_bib177","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2017.27","article-title":"Diminishing effectiveness of long-term maintenance topical steroid therapy in PPI non-responsive eosinophilic esophagitis","volume":"8","author":"Eluri","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib178","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib179","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s12325-017-0525-8","article-title":"RPC4046, a novel anti-interleukin-13 antibody, blocks IL-13 binding to IL-13 alpha1 and alpha2 receptors: a randomized, double-blind, placebo-controlled, dose-escalation first-in-human study","volume":"34","author":"Tripp","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaci.2026.06.004_bib180","doi-asserted-by":"crossref","first-page":"744","DOI":"10.14309\/ajg.0000000000002094","article-title":"Dysphagia days as an assessment of clinical treatment outcome in eosinophilic esophagitis","volume":"118","author":"Hirano","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib181","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S2468-1253(23)00204-2","article-title":"Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"8","author":"Rothenberg","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2026.06.004_bib182","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2500095","article-title":"Cendakimab in adults and adolescents with eosinophilic esophagitis","volume":"4","author":"Dellon","year":"2025","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jaci.2026.06.004_bib183","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14151","article-title":"Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Ralpha antibody, is required to broadly inhibit type 2 inflammation","volume":"75","author":"Le Floc\u2019h","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.06.004_bib184","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta(2)-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.06.004_bib185","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.06.004_bib186","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis","volume":"390","author":"Wechsler","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.06.004_bib187","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000501637","article-title":"AK002, a humanized sialic acid-binding immunoglobulin-like lectin-8 antibody that induces antibody-dependent cell-mediated cytotoxicity against human eosinophils and inhibits mast cell-mediated anaphylaxis in mice","volume":"180","author":"Youngblood","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib188","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.14309\/01.ajg.0000858424.48968.ad","article-title":"Results from KRYPTOS, a phase 2\/3 study of lirentelimab (AK002) in adults and adolescents with EoE","volume":"117","author":"Dellon","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.06.004_bib189","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","article-title":"TGFbeta biology in cancer progression and immunotherapy","volume":"18","author":"Derynck","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jaci.2026.06.004_bib190","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.4049\/jimmunol.1301843","article-title":"TGF-beta: guardian of T cell function","volume":"191","author":"Oh","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib191","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jaci.2026.06.004_bib192","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.15420\/cfr.2021.30","article-title":"Pirfenidone for idiopathic pulmonary fibrosis and beyond","volume":"8","author":"Aimo","year":"2022","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.jaci.2026.06.004_bib193","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejps.2014.02.014","article-title":"Effect of pirfenidone on proliferation, TGF-beta-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts","volume":"58","author":"Conte","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jaci.2026.06.004_bib194","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/cells9030775","article-title":"Pirfenidone inhibits cell proliferation and collagen I production of primary human intestinal fibroblasts","volume":"9","author":"Cui","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2026.06.004_bib195","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/14728222.2024.2375375","article-title":"Potential of alphavbeta6 and alphavbeta1 integrin inhibition for treatment of idiopathic pulmonary fibrosis","volume":"28","author":"Bellani","year":"2024","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jaci.2026.06.004_bib196","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12931-021-01863-0","article-title":"Dual inhibition of alpha(v)beta(6) and alpha(v)beta(1) reduces fibrogenesis in lung tissue explants from patients with IPF","volume":"22","author":"Decaris","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2026.06.004_bib197","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jaci.2010.06.010","article-title":"Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease","volume":"126","author":"Moreira","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.06.004_bib198","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1001\/jama.2018.6129","article-title":"Effect of recombinant human pentraxin 2 vs placebo on change in forced vital capacity in patients with idiopathic pulmonary fibrosis: a randomized clinical trial","volume":"319","author":"Raghu","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2026.06.004_bib199","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12950-023-00360-z","article-title":"Advances in the study of macrophage polarization in inflammatory immune skin diseases","volume":"20","author":"Xia","year":"2023","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.jaci.2026.06.004_bib200","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2020.00259","article-title":"Inhaled phosphodiesterase 4 (PDE4) inhibitors for inflammatory respiratory diseases","volume":"11","author":"Phillips","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2026.06.004_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173508","article-title":"A novel phosphodiesterase 4 inhibitor, AA6216, reduces macrophage activity and fibrosis in the lung","volume":"885","author":"Matsuhira","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2026.06.004_bib202","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa2201737","article-title":"Trial of a preferential phosphodiesterase 4B inhibitor for idiopathic pulmonary fibrosis","volume":"386","author":"Richeldi","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.06.004_bib203","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1053\/j.gastro.2023.01.006","article-title":"Injectable, drug-eluting nanocrystals prevent fibrosis and stricture formation in vivo","volume":"164","author":"Li","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.06.004_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102377","article-title":"Resmetirom\u2019s approval: highlighting the need for comprehensive approaches in NASH therapeutics","volume":"48","author":"Alshehade","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926004203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926004203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T09:19:59Z","timestamp":1785921599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926004203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":203,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0091674926004203"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.06.004","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue remodeling in eosinophilic esophagitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}